Toon Van Gorp

Professor

Universitaire Ziekenhuizen Leuven

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Cancer Biology Cancer Biology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (6)

Cristina Rodriguez-Antona

Investigador Científico/ Head

Instituto de Investigaciones Biomédicas Alberto Sols

SPAIN

View details

Dearbhaile Collins

Senior Lecturer in Cancer Research

University College Cork

IRELAND

View details

ANA OAKNIN

Head of Gynecological Cancer Program

Hospital Universitari Vall d'Hebron

SPAIN

View details

Michael Anglesio

Assistant Professor

The University of British Columbia

CANADA

View details

Frédéric Amant

Antoni van Leeuwenhoek Nederlands Kanker Instituut

NETHERLANDS

View details

Margaritis Avgeris

Associate Professor

National and Kapodistrian University of Athens - Faculty of Medicine

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Toon Van Gorp

Research Interests

Explore related searches

Contact this professor

Articles (9)

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI

tRNA-derived small RNA 3'U-tRFValCAC promotes tumour migration and early progression in ovarian cancer

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study

Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)

CLINICAL BENEFIT OF MIRVETUXIMAB SORAVTANSINE IN OVARIAN CANCER PATIENTS WITH HIGH FOLATE RECEPTOR ALPHA EXPRESSION: RESULTS FROM THE SORAYA STUDY

Collaborators (6)

Cristina Rodriguez-Antona

Dearbhaile Collins

ANA OAKNIN

Michael Anglesio

Frédéric Amant

Margaritis Avgeris

Make your next move.